Australasian Gastro-intestinal Trials Group

This study tests whether adding an immunotherapy drug (durvalumab) to standard chemotherapy before surgery is safe and doable for people with pancreatic cancer that can be removed. About 20 adults with early-stage disease will receive the combination treatment. The main goal is t…

This study tests whether adding a targeted treatment (local ablative therapy) to standard chemotherapy can help people with colorectal cancer that has spread to a few spots live longer without the cancer growing. About 6 participants whose cancer responded to initial chemotherapy…

This study tests whether adding valproate (a drug used for seizures) to standard antibody therapy can help control metastatic colorectal cancer longer. About 38 adults with a specific genetic type (RAS wild type) will receive the combination after initial treatment. The goal is t…